Endo International | Passivo Circulante



Current Liabilities Alterar Data
AbbVie USD 38.75B 4.31B 2024-12
Amarin USD 162.41M 17.54M 2025-03
ANI Pharmaceuticals USD 201.82M 8.14M 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Eli Lilly USD 30.07B 1.69B 2025-03
Hikma Pharmaceutical USD 1.98B 598M 2024-12
Ligand Pharmaceuticals USD 58.68M 21.57M 2025-03
Merck USD 25.17B 3.25B 2025-03
Novartis USD 28.69B 560M 2024-12
Pacira USD 314.73M 4.81M 2025-03
Perrigo USD 1.07B 29.6M 2025-03
Pfizer USD 36.45B 6.54B 2025-03
Supernus Pharmaceuticals USD 292.4M 889K 2024-12
Takeda JPY 2.51T 408.56B 2025-03
Teva Pharmaceutical Industries USD 11.16B 1.64B 2025-03
Xeris Pharmaceuticals USD 100.44M 9.43M 2024-12
Zoetis USD 3.38B 27M 2025-03



Endo International Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.